Jason O'Byrne
Equibles does not estimate personal net worth.
Get an email with a short summary when Vir Biotechnology, Inc. publishes a filing, an earnings call transcript or a press release.
Get VIR alertsAbout Jason O'Byrne
Jason O'Byrne is recorded as CFO at Vir Biotechnology, Inc. (VIR) since October 2, 2024. Vir Biotechnology, Inc. reported in an 8-K filed September 10, 2024 that Jason O'Byrne was appointed Executive Vice President and Chief Financial Officer, effective October 2, 2024. Vir Biotechnology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vir Biotechnology, Inc. includes Marianne De Backer, MSc, Ph.D., MBA (CEO and Board Member), Aziz Sawaf (CFO), Brent Sabatini (CFO) and 7 others.
“On September 10, 2024, the Company announced that Jason O’Byrne, MBA, has been appointed as Executive Vice President and Chief Financial Officer and “principal financial officer” of the Company, effective as of October 2, 2024 (the “Effective Date”).”
Affiliation history
-
Current
2024-10-02–present
Company network
Leadership on record at Vir Biotechnology, Inc.
- Marianne De Backer, MSc, Ph.D., MBA CEO, Board Member
- Aziz Sawaf CFO
- Brent Sabatini CFO
- Howard Horn CFO
- Johanna Friedl-Naderer COO
- Michael Kamarck CTO
- Vanina de Verneuil General Counsel
- Elliott Sigal Board Member
- Janet Napolitano Board Member
- Robert More Board Member